Literature DB >> 9611242

The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.

F Rossi1, E Labourier, I E Gallouzi, J Derancourt, E Allemand, G Divita, J Tazi.   

Abstract

Human DNA topoisomerase I not only has DNA relaxing activity, but also splicing factors phosphorylating activity. Topo I shows strong preference for ATP as the phosphate donor. We used photoaffinity labeling with the ATP analogue [alpha-32P] 8-azidoadenosine-5'-triphosphate combined with limited proteolysis to characterize Topo I domains involved in ATP binding. The majority of incorporated analogue was associated with two fragments derived from N-terminal and C-terminal regions of Topo I, respectively. However, mutational analysis showed that deletion of the first 138 N-terminal residues, known to be dispensable for topoisomerase activity, did not change the binding of ATP or the kinase activity. In contrast, deletion of 162 residues from the C-terminal domain was deleterious for ATP binding, kinase and topoisomerase activities. Furthermore, a C-terminal tyrosine 723 mutant lacking topoisomerase activity is still able to bind ATP and to phosphorylate SF2/ASF, suggesting that the two functions of Topo I can be separated. These findings argue in favor of the fact that Topo I is a complex enzyme with a number of potential intra-cellular functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9611242      PMCID: PMC147659          DOI: 10.1093/nar/26.12.2963

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

Review 1.  DNA topoisomerases: why so many?

Authors:  J C Wang
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

2.  Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.

Authors:  S H Xiao; J L Manley
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

Review 3.  DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?

Authors:  J Tazi; F Rossi; E Labourier; I Gallouzi; C Brunel; E Antoine
Journal:  J Mol Med (Berl)       Date:  1997 Nov-Dec       Impact factor: 4.599

4.  Targeted disruption of the mouse topoisomerase I gene by camptothecin selection.

Authors:  S G Morham; K D Kluckman; N Voulomanos; O Smithies
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

Review 5.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.

Authors:  P D'Arpa; P S Machlin; H Ratrie; N F Rothfield; D W Cleveland; W C Earnshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  Cloning, characterization, and sequence of the yeast DNA topoisomerase I gene.

Authors:  C Thrash; A T Bankier; B G Barrell; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators.

Authors:  A R Krainer; A Mayeda; D Kozak; G Binns
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

10.  Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization.

Authors:  T Uemura; M Yanagida
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  10 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

2.  Pea DNA topoisomerase I is phosphorylated and stimulated by casein kinase 2 and protein kinase C.

Authors:  Narendra Tuteja; Malireddy Kodandarami Reddy; Yashwanti Mudgil; Badam Singh Yadav; Meena Rani Chandok; Sudhir Kumar Sopory
Journal:  Plant Physiol       Date:  2003-08       Impact factor: 8.340

3.  Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.

Authors:  Johann Soret; Nadia Bakkour; Sophie Maire; Sébastien Durand; Latifa Zekri; Mathieu Gabut; Weronika Fic; Gilles Divita; Christian Rivalle; Daniel Dauzonne; Chi Hung Nguyen; Philippe Jeanteur; Jamal Tazi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

Review 4.  DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde?

Authors:  A K Larsen; C Gobert
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

5.  Human topoisomerase I C-terminal domain fragment containing the active site tyrosine is a molten globule: implication for the formation of competent productive complex.

Authors:  Chandanamali Punchihewa; Jixun Dai; Megan Carver; Danzhou Yang
Journal:  J Struct Biol       Date:  2007-03-12       Impact factor: 2.867

6.  Interaction of human DNA topoisomerase I with G-quartet structures.

Authors:  P B Arimondo; J F Riou; J L Mergny; J Tazi; J S Sun; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

7.  Distinctive features of Drosophila alternative splicing factor RS domain: implication for specific phosphorylation, shuttling, and splicing activation.

Authors:  E Allemand; R Gattoni; H M Bourbon; J Stevenin; J F Cáceres; J Soret; J Tazi
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

8.  The SR protein B52/SRp55 is required for DNA topoisomerase I recruitment to chromatin, mRNA release and transcription shutdown.

Authors:  François Juge; Céline Fernando; Weronika Fic; Jamal Tazi
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

9.  ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism.

Authors:  Souvik Sengupta; Agneyo Ganguly; Amit Roy; Somdeb Bosedasgupta; Ilda D'Annessa; Alessandro Desideri; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2010-12-23       Impact factor: 16.971

Review 10.  Why Should DNA Topoisomerase I Have a Scaffold Activity?

Authors:  Francesca Di Felice; Giorgio Camilloni
Journal:  Biology (Basel)       Date:  2021-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.